Clinical Trial Update: Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study of BMS-907351 (XL184) in Japanese patients with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BMS-907351 (XL184) (BMS-907351)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Neoplasms | Phase 1 | Status: COMPLETED